This CME conference will review new medications and therapies that are now available, or will soon be available, and discuss their comparative values. The results of trials using new drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, cholangiocarcinoma, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.
Half Day Pre-Conference Seminar reviewing the virology, genotypes and modes of infection of HCV.
Plenary talks from nationally recognized experts.
Presentations on hot topics, upcoming scientific developments, and current advances in chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease.
Networking opportunities among colleagues.
Conference app with access to course materials from the convenience of your mobile device or computer.
Claim up to 13.5 AMA PRA Category 1 Credit(s)™
Infectious Disease Specialists
Others desiring an update in these specialty areas
For more information contact:
Scripps Conference Services & CME
4275 Campus Point Court, CPB 205
San Diego, California 92121
Phone: (858) 678-6400